Dexcom (DXCM) Tax Provisions (2012 - 2026)

Dexcom (DXCM) has 13 years of Tax Provisions data on file, last reported at $70.0 million in Q1 2026.

• On a quarterly basis, Tax Provisions rose 43.15% year-over-year to $70.0 million in Q1 2026; TTM through Mar 2026 was $273.2 million, a 39.67% increase from a year earlier, with the FY2025 full-year figure at $252.1 million, up 89.83% from the prior year.
• Tax Provisions for Q1 2026 stood at $70.0 million, down from $73.4 million in the prior quarter.
• Over the last five years, Tax Provisions for DXCM reached as high as $119.7 million in Q3 2023 and fell as low as -$61.2 million in Q1 2022.
• Historically, Tax Provisions has averaged $39.6 million across 5 years, with a median of $44.3 million in 2024.
• Across the five-year window, Tax Provisions plunged 302.63% in 2022 and surged 690.1% in 2024, its largest moves.
• Year by year, Tax Provisions stood at $41.4 million in 2022, then slumped by 124.4% to -$10.1 million in 2023, then jumped by 690.1% to $59.6 million in 2024, then rose by 23.15% to $73.4 million in 2025, then slipped by 4.63% to $70.0 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $70.0 million in Q1 2026, $73.4 million in Q4 2025, and $68.5 million in Q3 2025.